Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 8.7B | 8.9B | 9.4B | 8.9B |
| Cost of revenue | 2.2B | 2.4B | 2.4B | 2.4B |
| Gross profit | 6.6B | 6.5B | 7.1B | 6.5B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 1.8B | -287M | 1.7B | 1.6B |
| Operating income | 1B | 2.4B | 1.7B | 1.3B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 116M | 120M | 124M | 131M |
| Other income expense | — | — | — | — |
| Pretax income | 1.0B | 2.4B | 1.8B | 1.4B |
| Tax provision | 146M | 572M | 497M | 312M |
| Net income | 867M | 1.8B | 1.3B | 1.1B |
| Basic EPS | 2.2 | — | 3.3 | 2.6 |
| Diluted EPS | 2.2 | — | 3.3 | 2.6 |
| Basic average shares | 401.4M | — | 400.9M | 401.9M |
| Diluted average shares | 403.3M | — | 402.1M | 401.9M |
| EBITDA | 2.2B | 3.5B | 3.0B | 2.6B |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 0 | 0 | 0 | 0 |